Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

JOSE MARIA BORREGO ACOSTA

Allopathic & Osteopathic Physicians Family Medicine

NPI
1598807216
CMS profile
117874
Location
OKLAHOMA CITY, OK

General Payments · PY2022–2025

$105,913.06

  • Reported across 42 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$29,700.00

11 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $29,700.00 11

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $29,700.00 11

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $23,213.06 11
PY2023 $20,800.00 8
PY2024 $32,200.00 12
PY2025 $29,700.00 11

Payment records · PY2025 (11)

Sorted by paying entity, then date · as published by CMS

Program year 2025 202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 01/17/2025 Consulting Fee Undisputed 06/30/2026 1223791358 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 02/12/2025 Consulting Fee Undisputed 06/30/2026 1223791360 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 03/12/2025 Consulting Fee Undisputed 06/30/2026 1223791362 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 04/11/2025 Consulting Fee Undisputed 06/30/2026 1223791364 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 05/09/2025 Consulting Fee Undisputed 06/30/2026 1223791366 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 06/11/2025 Consulting Fee Undisputed 06/30/2026 1223791368 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 07/11/2025 Consulting Fee Undisputed 06/30/2026 1223791370 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 08/08/2025 Consulting Fee Undisputed 06/30/2026 1223791372 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 09/10/2025 Consulting Fee Undisputed 06/30/2026 1223791374 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 10/08/2025 Consulting Fee Undisputed 06/30/2026 1223791376 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 11/12/2025 Consulting Fee Undisputed 06/30/2026 1223791378 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.